These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 8470245)
1. Quadruple-drug therapy with antithymocyte globulin in the early postoperative period after liver transplantation. Schattenfroh N; Lange D; Bechstein WO; Blumhardt G; Lohmann R; Neuhaus P Transplant Proc; 1993 Apr; 25(2):1968-9. PubMed ID: 8470245 [No Abstract] [Full Text] [Related]
2. Interleukin-2 receptor antibody versus antithymocyte globulin as part of quadruple induction therapy after orthotopic liver transplantation: a randomized study. Langrehr JM; Guckelberger O; Nüssler N; Radtke A; Lemmens HP; Jonas S; Lohmann R; Tullius S; Steinmüller T; Raakow R; Neumann U; Knoop M; Bechstein WO; Neuhaus P Transplant Proc; 1996 Dec; 28(6):3204. PubMed ID: 8962241 [No Abstract] [Full Text] [Related]
3. Quadruple induction immunosuppression after liver transplantation with interleukin-2 receptor antibody (BT 563) is equally effective and better tolerated than antithymocyte globulin induction therapy. Neuhaus P; Bechstein WO; Blumhardt G; Steffen R; Keck H; Lemmens P; Langrehr JM; Schlag H Transplant Proc; 1993 Apr; 25(2):1940-1. PubMed ID: 8470234 [No Abstract] [Full Text] [Related]
4. Induction therapy including antithymocyte globulin induces marked alterations in T lymphocyte subpopulations after liver transplantation: results of a long-term study. Oertel M; Sack U; Kohlhaw K; Lehmann I; Emmrich F; Berr F; Hauss J; Schwarz R Transpl Int; 2002 Oct; 15(9-10):463-71. PubMed ID: 12389078 [TBL] [Abstract][Full Text] [Related]
5. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results. Schulz T; Kapischke M; Busing M Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475 [TBL] [Abstract][Full Text] [Related]
6. Incidence and outcome of OKT3 treatment for early steroid-resistant rejection following hepatic transplantation. Lange D; Bechstein WO; Blumhardt G; Lemmens P; Schattenfroh N; Neuhaus P Transplant Proc; 1993 Apr; 25(2):1870-1. PubMed ID: 8470207 [No Abstract] [Full Text] [Related]
7. Liver transplantation in hepatitis B surface antigen positive patients with postoperative long-term immunoprophylaxis. Langrehr JM; Lemmens HP; Keck H; Lohmann R; Knoop M; Neumann U; Müller AR; Platz KP; Kling N; Hopf U Transplant Proc; 1995 Feb; 27(1):1215-6. PubMed ID: 7533373 [No Abstract] [Full Text] [Related]
8. Quadruple induction immunosuppression after liver transplantation with IL-2 receptor antibody (BT 563) is equally effective and better tolerated than ATG induction therapy. Neuhaus B; Keck H; Bechstein WO; Blumhardt G; Langrehr JM; Wiens M; Lemmens HP; Lohmann R; Schlag H; Thalmann U Transplant Proc; 1993 Feb; 25(1 Pt 1):587-9. PubMed ID: 8438426 [No Abstract] [Full Text] [Related]
9. Quadruple induction therapy including antithymocyte globulin or interleukin-2 receptor antibody or FK 506-based induction therapy after liver transplantation. Lohmann R; Langrehr JM; Klupp J; Neumann U; Guckelberger O; Müller AR; Nüssler NC; Jonas S; Lang M; Settmacher U; Bechstein WO; Neuhaus PJ Transplant Proc; 1999; 31(1-2):380. PubMed ID: 10083151 [No Abstract] [Full Text] [Related]
10. Optimal immunosuppressive clinical regimen in liver transplantation. Farges O; Samuel D; Bismuth H Transplant Proc; 1994 Oct; 26(5):2676-8. PubMed ID: 7940838 [No Abstract] [Full Text] [Related]
11. Impact of primary immunosuppression on the incidence of infectious complications after orthotopic liver transplantation. Lohmann R; Langrehr JM; Raakow R; Jonas S; Klupp J; Steinmüller T; Neuhaus R; Neuhaus P Transplant Proc; 2000 Nov; 32(7):2229-30. PubMed ID: 11120145 [No Abstract] [Full Text] [Related]
12. Anti-interleukin 2 monoclonal antibody following simultaneous pancreatic and kidney transplantation: a randomized trial vs rabbit antithymocyte globulin. Cantarovich D; Hourmant M; Dantal J; Baatard R; Le Mauff B; Jacques Y; Paineau J; Murat A; Soulillou JP Transplant Proc; 1993 Feb; 25(1 Pt 2):1366. PubMed ID: 8442143 [No Abstract] [Full Text] [Related]
13. Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563. Langrehr JM; Lohmann R; Raakow R; Jonas S; Klupp J; Bechstein WO; Neuhaus R; Neuhaus P Transplant Proc; 2001 May; 33(3):2290-1. PubMed ID: 11377531 [No Abstract] [Full Text] [Related]